Skip to main content
. 2023 Jun 2;20(7):3519–3528. doi: 10.1021/acs.molpharmaceut.3c00117

Figure 1.

Figure 1

Structures of NOTA-MI-exendin-4 (A), DOTA-MI-exendin-4 (B), and NODAGA-MI-exendin-4 (C).